Our present results confirmed elevated expression of HIF1-α and VEGF-A in glaucoma, and our findings suggest that PACAP is able to reduce the hypoxia-induced retinal and microvascular damage by decreasing HIF1-α and VEGF-A expression in glaucoma. The gene discussed is VEGFA; the disease is glaucoma.